Assembly Biosciences Inc (ASMB)
14.72
-0.30
(-2.00%)
USD |
NASDAQ |
Nov 21, 16:00
14.79
+0.07
(+0.48%)
After-Hours: 20:00
Assembly Biosciences Profit Margin (Quarterly): -140.4% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -140.4% |
| June 30, 2024 | -130.7% |
| March 31, 2024 | -156.9% |
| December 31, 2023 | -153.0% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | -300.7% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -3.80K% |
| Date | Value |
|---|---|
| September 30, 2020 | -9.68% |
| June 30, 2020 | 18.46% |
| March 31, 2020 | -653.1% |
| December 31, 2019 | -568.3% |
| September 30, 2019 | -590.8% |
| June 30, 2019 | -600.7% |
| March 31, 2019 | -696.3% |
| December 31, 2018 | -700.4% |
| September 30, 2018 | -502.4% |
| June 30, 2018 | -833.0% |
| March 31, 2018 | -455.8% |
| December 31, 2017 | -90.71% |
| September 30, 2017 | -461.4% |
| June 30, 2017 | -576.4% |
| March 31, 2017 | -2.04K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.80K%
Minimum
Dec 2020
18.46%
Maximum
Jun 2020
-589.6%
Average
-155.0%
Median
Profit Margin (Quarterly) Benchmarks
| ADMA Biologics Inc | 29.96% |
| Sensus Healthcare Inc | 13.75% |
| Protagonist Therapeutics Inc | -710.4% |
| Precision BioSciences Inc | -2.85K% |
| Entrada Therapeutics Inc | -71.70% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -115.9% |
| Return on Assets | -38.94% |
| Return on Invested Capital | -115.9% |
| Operating Margin (Quarterly) | -160.1% |
| Return on Net Operating Assets | -1.80K% |